XML 67 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure [Table]          
Pay vs Performance Disclosure, Table

PAY VERSUS PERFORMANCE

As required by Item 402(v) of Regulation S-K, we are providing the following information about the relationship between compensation actually paid (CAP), as defined in Item 402(v), and performance.

Year
(a)

Summary
Compensation
Table Total
for Principal
Executive Officer
(PEO)
(b)1

Compensation
Actually
Paid to PEO2,3
(c)

Average Summary
Compensation Table
Total for Non-PEO
Named Executive
Officers1
(d)

Average
Compensation
Actually Paid to
Non-PEO NEOs2,3
(e)

Value of Initial Fixed $100
Investment Based On:

Net
Income
(millions)5
(h)

Corporate
Operating
Income6
(millions)
(i)

Total
Shareholder
Return
(f)

Peer Group
Total
Shareholder
Return4
(g)

2024

$13,216,384

$11,169,734

$2,282,244

$2,148,332

$113

$126

$35.6

$209.4

2023

$7,299,862

$10,144,030

$1,253,550

$1,604,203

$125

$128

$139.1

$182.1

2022

$7,888,489

$11,227,698

$1,375,137

$1,771,361

$103

$112

$133.0

$213.3

2021

$9,897,900

$6,603,590

$1,668,578

$1,305,876

$90

$149

$93.1

$131.2

2020

$7,454,445

$5,431,868

$1,465,583

$1,135,176

$89

$116

$28.7

$63.2
(1)The PEO listed for 2020, 2021, 2022, 2023, and 2024 is Patrick S. Williams. The Non-PEO remaining NEOs for 2023 and 2024 are Ian P. Cleminson, Philip J. Boon, Corbin Barnes, and David B. Jones. The Non-PEO remaining NEOs for 2021 and 2022 are Ian P. Cleminson, Philip J. Boon, Ian M. McRobbie, and David B. Jones. The Non-PEO remaining NEOs for 2020 are Ian P. Cleminson, Philip J. Boon, Brian R. Watt, and Ian M. McRobbie.
(2)The following adjustments relating to equity awards were made to total compensation for each year to determine CAP:
(3)For 2024, no adjustments were made relating to defined benefit and pension plans to determine CAP.
(4)Represents the cumulative TSR for the S&P Composite 1500 Specialty Chemicals Index, as disclosed by Innospec for the purposes of Item 201(e) of Regulation S-K.
(5)The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable year (GAAP Net Income).
(6)Corporate Operating Income is the financial performance measure used by the Company in the most recently completed fiscal year to link CAP to the Company’s performance. Corporate Operating Income is calculated from GAAP Operating Income adjusted to exclude certain one-time/nonrecurring costs that are not reflective of the Company’s underlying operations, as further described in the Compensation Discussion and Analysis.

(1)The PEO listed for 2020, 2021, 2022, 2023, and 2024 is Patrick S. Williams. The Non-PEO remaining NEOs for 2023 and 2024 are Ian P. Cleminson, Philip J. Boon, Corbin Barnes, and David B. Jones. The Non-PEO remaining NEOs for 2021 and 2022 are Ian P. Cleminson, Philip J. Boon, Ian M. McRobbie, and David B. Jones. The Non-PEO remaining NEOs for 2020 are Ian P. Cleminson, Philip J. Boon, Brian R. Watt, and Ian M. McRobbie.

(2)The following adjustments relating to equity awards were made to total compensation for each year to determine CAP:

Year

Value of Equity Awards
Disclosed in the Summary
Compensation Table

Year End Value of
Equity Awards
Granted During the
Covered Year

Change in Fair
Value from Prior
Year End Fair Value
of Outstanding and
Unvested Equity Awards

Change in Fair Value from
Prior Year End Fair Value
of Awards Granted in
Prior Years Vesting During
the Covered Year

Total Equity
Award
Adjustments

2024 PEO

($5,332,447)

$4,716,328

($1,392,038)

($38,493)

($2,046,650)

2024 Average Non-PEO NEOs

($565,834)

$617,831

($180,651)

($5,258)

($133,912)

(a)The valuation methodologies used to calculate fair values for each measurement date do not materially differ from those used at the time of grant of each respective award.

(1)For 2024, no adjustments were made relating to defined benefit and pension plans to determine CAP.

(2)Represents the cumulative TSR for the S&P Composite 1500 Specialty Chemicals Index, as disclosed by Innospec for the purposes of Item 201(e) of Regulation S-K.

(3)The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable year (GAAP Net Income).

(4)Corporate Operating Income is the financial performance measure used by the Company in the most recently completed fiscal year to link CAP to the Company’s performance. Corporate Operating Income is calculated from GAAP Operating Income adjusted to exclude certain one-time/nonrecurring costs that are not reflective of the Company’s underlying operations, as further described in the Compensation Discussion and Analysis.

        
Company Selected Measure Name Corporate Operating Income        
Named Executive Officers, Footnote [Text Block]

(1)The PEO listed for 2020, 2021, 2022, 2023, and 2024 is Patrick S. Williams. The Non-PEO remaining NEOs for 2023 and 2024 are Ian P. Cleminson, Philip J. Boon, Corbin Barnes, and David B. Jones. The Non-PEO remaining NEOs for 2021 and 2022 are Ian P. Cleminson, Philip J. Boon, Ian M. McRobbie, and David B. Jones. The Non-PEO remaining NEOs for 2020 are Ian P. Cleminson, Philip J. Boon, Brian R. Watt, and Ian M. McRobbie.

        
PEO Total Compensation Amount [1] $ 13,216,384 $ 7,299,862 $ 7,888,489 $ 9,897,900 $ 7,454,445
PEO Actually Paid Compensation Amount [2],[3] $ 11,169,734 10,144,030 11,227,698 6,603,590 5,431,868
Adjustment To PEO Compensation, Footnote

Year

Value of Equity Awards
Disclosed in the Summary
Compensation Table

Year End Value of
Equity Awards
Granted During the
Covered Year

Change in Fair
Value from Prior
Year End Fair Value
of Outstanding and
Unvested Equity Awards

Change in Fair Value from
Prior Year End Fair Value
of Awards Granted in
Prior Years Vesting During
the Covered Year

Total Equity
Award
Adjustments

2024 PEO

($5,332,447)

$4,716,328

($1,392,038)

($38,493)

($2,046,650)

2024 Average Non-PEO NEOs

($565,834)

$617,831

($180,651)

($5,258)

($133,912)

(a)The valuation methodologies used to calculate fair values for each measurement date do not materially differ from those used at the time of grant of each respective award.

        
Non-PEO NEO Average Total Compensation Amount [1] $ 2,282,244 1,253,550 1,375,137 1,668,578 1,465,583
Non-PEO NEO Average Compensation Actually Paid Amount [2],[3] $ 2,148,332 1,604,203 1,771,361 1,305,876 1,135,176
Adjustment to Non-PEO NEO Compensation Footnote

Year

Value of Equity Awards
Disclosed in the Summary
Compensation Table

Year End Value of
Equity Awards
Granted During the
Covered Year

Change in Fair
Value from Prior
Year End Fair Value
of Outstanding and
Unvested Equity Awards

Change in Fair Value from
Prior Year End Fair Value
of Awards Granted in
Prior Years Vesting During
the Covered Year

Total Equity
Award
Adjustments

2024 PEO

($5,332,447)

$4,716,328

($1,392,038)

($38,493)

($2,046,650)

2024 Average Non-PEO NEOs

($565,834)

$617,831

($180,651)

($5,258)

($133,912)

(a)The valuation methodologies used to calculate fair values for each measurement date do not materially differ from those used at the time of grant of each respective award.

        
Compensation Actually Paid vs. Total Shareholder Return

The graphics below depict the relationship between CAP and Company TSR, S&P Composite 1500 Specialty Chemicals Index TSR (referred to as the “peer group TSR” for purposes of 402(v)), and financial performance.

        
Compensation Actually Paid vs. Net Income

The graphics below depict the relationship between CAP and Company TSR, S&P Composite 1500 Specialty Chemicals Index TSR (referred to as the “peer group TSR” for purposes of 402(v)), and financial performance.

        
Total Shareholder Return Vs Peer Group

The graphics below depict the relationship between CAP and Company TSR, S&P Composite 1500 Specialty Chemicals Index TSR (referred to as the “peer group TSR” for purposes of 402(v)), and financial performance.

        
Tabular List, Table

Tabular List of Financial Performance Measures

The most important financial performance measures used by the Company to link executive CAP to the Company’s PEO and NEOs, for the most recently completed fiscal year, to the Company’s performance are as follows:

•Corporate Operating Income

•EPS

•Cash Flow

•Revenue

•Relative TSR

        
Total Shareholder Return Amount $ 113 125 103 90 89
Peer Group Total Shareholder Return Amount [4] 126 128 112 149 116
Net Income (Loss) Attributable to Parent [5] $ 35,600,000 $ 139,100,000 $ 133,000,000.0 $ 93,100,000 $ 28,700,000
Company Selected Measure Amount [6] 209,400,000 182,100,000 213,300,000 131,200,000 63,200,000
PEO Name Patrick S. Williams Patrick S. Williams Patrick S. Williams Patrick S. Williams Patrick S. Williams
Measure [Axis]: 1          
Pay vs Performance Disclosure [Table]          
Measure Name Corporate Operating Income        
Measure [Axis]: 2          
Pay vs Performance Disclosure [Table]          
Measure Name EPS        
Measure [Axis]: 3          
Pay vs Performance Disclosure [Table]          
Measure Name Cash Flow        
Measure [Axis]: 4          
Pay vs Performance Disclosure [Table]          
Measure Name Revenue        
Measure [Axis]: 5          
Pay vs Performance Disclosure [Table]          
Measure Name Relative TSR        
PEO [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount $ (5,332,447)        
PEO [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount 4,716,328        
PEO [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount (1,392,038)        
PEO [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount (38,493)        
PEO [Member] | Equity Awards Adjustments [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount (2,046,650)        
Non-PEO NEO [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount (565,834)        
Non-PEO NEO [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount 617,831        
Non-PEO NEO [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount (180,651)        
Non-PEO NEO [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount (5,258)        
Non-PEO NEO [Member] | Equity Awards Adjustments [Member]          
Pay vs Performance Disclosure [Table]          
Adjustment to Compensation Amount $ (133,912)        
[1] The PEO listed for 2020, 2021, 2022, 2023, and 2024 is Patrick S. Williams. The Non-PEO remaining NEOs for 2023 and 2024 are Ian P. Cleminson, Philip J. Boon, Corbin Barnes, and David B. Jones. The Non-PEO remaining NEOs for 2021 and 2022 are Ian P. Cleminson, Philip J. Boon, Ian M. McRobbie, and David B. Jones. The Non-PEO remaining NEOs for 2020 are Ian P. Cleminson, Philip J. Boon, Brian R. Watt, and Ian M. McRobbie.
[2] For 2024, no adjustments were made relating to defined benefit and pension plans to determine CAP.
[3] The following adjustments relating to equity awards were made to total compensation for each year to determine CAP:
[4] Represents the cumulative TSR for the S&P Composite 1500 Specialty Chemicals Index, as disclosed by Innospec for the purposes of Item 201(e) of Regulation S-K.
[5] The dollar amounts reported represent the amount of net income reflected in the Company’s audited financial statements for the applicable year (GAAP Net Income).
[6] Corporate Operating Income is the financial performance measure used by the Company in the most recently completed fiscal year to link CAP to the Company’s performance. Corporate Operating Income is calculated from GAAP Operating Income adjusted to exclude certain one-time/nonrecurring costs that are not reflective of the Company’s underlying operations, as further described in the Compensation Discussion and Analysis.